ES2061752T3 - 11 beta, 17 alfa, 21-trihidroxi-1,4-pregnadieno-3,20-diona-21-((e,e)-3,7,11-trimetil-2,6,10-dodecatrienoato). - Google Patents

11 beta, 17 alfa, 21-trihidroxi-1,4-pregnadieno-3,20-diona-21-((e,e)-3,7,11-trimetil-2,6,10-dodecatrienoato).

Info

Publication number
ES2061752T3
ES2061752T3 ES89104010T ES89104010T ES2061752T3 ES 2061752 T3 ES2061752 T3 ES 2061752T3 ES 89104010 T ES89104010 T ES 89104010T ES 89104010 T ES89104010 T ES 89104010T ES 2061752 T3 ES2061752 T3 ES 2061752T3
Authority
ES
Spain
Prior art keywords
trihidroxi
dodecatrienoato
pregnadieno
trimetil
diona
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89104010T
Other languages
English (en)
Inventor
Yutaka Mizushima
Keiko Hoshi
Rie Igarashi
Hirofusa Aza-Nagaebouji Ajioka
Noriyuki Yamamoto
Masahito Komuro
Koichi Kanehira
Masayuki Inoue
Takashi Nishida
Manzo Shiono
Michio Terasawa
Kenzo Arizono
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kuraray Co Ltd
Taiho Pharmaceutical Co Ltd
Original Assignee
Kuraray Co Ltd
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Co Ltd, Taiho Pharmaceutical Co Ltd filed Critical Kuraray Co Ltd
Application granted granted Critical
Publication of ES2061752T3 publication Critical patent/ES2061752T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN COMPUESTO COMO EL DEL TITULO DE FORMULA(I), UNA COMPOSICION ANTIINFLAMATORIA DE ESTO Y UN METODO PARA SU PRODUCCION. EL COMPUESTO ANTERIOS DE LA PRESENTE INVENCION MUESTRA UNA MARCADA ACCION ANTIINFLAMATORIA Y ADEMAS, TIENE EFECTOS SECUNDARIOS REDUCIDOS, Y SE PUEDE PRODUCIR CON UNA ALTA SELECTIVIDAD Y UN BUEN RENDIMIENTO.
ES89104010T 1988-03-09 1989-03-07 11 beta, 17 alfa, 21-trihidroxi-1,4-pregnadieno-3,20-diona-21-((e,e)-3,7,11-trimetil-2,6,10-dodecatrienoato). Expired - Lifetime ES2061752T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5713588 1988-03-09
JP8054288 1988-03-31

Publications (1)

Publication Number Publication Date
ES2061752T3 true ES2061752T3 (es) 1994-12-16

Family

ID=26398157

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89104010T Expired - Lifetime ES2061752T3 (es) 1988-03-09 1989-03-07 11 beta, 17 alfa, 21-trihidroxi-1,4-pregnadieno-3,20-diona-21-((e,e)-3,7,11-trimetil-2,6,10-dodecatrienoato).

Country Status (5)

Country Link
US (1) US5015746A (es)
EP (1) EP0332143B1 (es)
CA (1) CA1326662C (es)
DE (1) DE68913778T2 (es)
ES (1) ES2061752T3 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
WO1998050041A1 (en) * 1997-05-06 1998-11-12 Imarx Pharmaceutical Corp. Novel prodrugs comprising fluorinated amphiphiles
US7825147B2 (en) * 2003-08-29 2010-11-02 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
WO2005051931A2 (en) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
BRPI0617673C1 (pt) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd composições de inibidores de fosfodiesterase do tipo iv
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
NZ579645A (en) 2007-03-14 2012-01-12 Ranbaxy Lab Ltd Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN105272854A (zh) * 2014-05-27 2016-01-27 重庆圣华曦药业股份有限公司 一种吉法酯的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187395A (en) * 1966-07-15 1970-04-08 Angeli Inst Spa Terpenic, Homoterpenic and Terpenylacetic Acid Esters ofSteroid 21-ols
JPS61229824A (ja) * 1985-04-05 1986-10-14 Yutaka Mizushima 経皮吸収型ステロイド外用剤

Also Published As

Publication number Publication date
DE68913778D1 (de) 1994-04-21
DE68913778T2 (de) 1994-07-28
EP0332143B1 (en) 1994-03-16
CA1326662C (en) 1994-02-01
US5015746A (en) 1991-05-14
EP0332143A1 (en) 1989-09-13

Similar Documents

Publication Publication Date Title
ES2061752T3 (es) 11 beta, 17 alfa, 21-trihidroxi-1,4-pregnadieno-3,20-diona-21-((e,e)-3,7,11-trimetil-2,6,10-dodecatrienoato).
IT1232669B (it) Procedimento per la produzione di urea con elevato rendimento energetico.
DE3689134D1 (de) Kathode für Elektronenröhre.
IT7822138A0 (it) Procedimento per fabbricare corpi metallici duri di elevata resistenza all'usura.
ES493474A0 (es) Procedimiento para producir el compuesto (n-fosfonacetil-l- aspartato) (1,2-diaminociclohexano) platino (ii).
IT8519896A0 (it) Pneumatico con fascia di rinforzo.
NO170310C (no) Elektronstraalestyrt bryter med radiell geometri
ES2054106T3 (es) Acetales de oxotetralinas y de oxoindanos.
GB2165761A (en) Bipolar double-acting electrocoagulator
ES516814A0 (es) Procedimiento para convertir un compuesto de oxi-azufre de metal alcalino en el sulfuro de metal alcalino correspondiente.
ES2090530T3 (es) Produccion de peces mejorada.
IT8421426A0 (it) Procedimento per la pirolisi di peci fenoliche.
IT7831352A0 (it) Processo per l'alchilazione di 4(5)-mercaptometil-imidazoli con derivati aziridinici.
ITRM910621A0 (it) Procedimento per la fabbricazione di transistori con struttura gate -isolante -semiconduttore.
ES1011479Y (es) Boquilla para suprimir el alquitran.
FI853652A7 (fi) Tyydyttämättömiin alkoholitioeettereihin perustuvia, uusia polymeereja.
ES528104A0 (es) Procedimiento para fabricar un producto detergente organico sintetico en particulas. como divisional de la solicitud de patente de invencion n 521.439 presentada el 14 de abril de 1983.
AR215308A1 (es) Procedimiento para producir el compuesto antibiotico 64,192
IT8423941A0 (it) Procedimento di fabbricazione di un articolo per estrusione, e articolo ottenuto.
IT1199640B (it) (16,17-a)ciclopentano pregneni ad attivita'antiinfiammatoria
JPS5629346A (en) Division of wafer
USD180536S (en) Fluorescent lighting fixture
EP0178676A3 (en) Antigenic peptide compounds
ATE26768T1 (de) Emissionselektronenmikroskop.
IT8420739U1 (it) Porta lumino votivo provvisto di deformazioni periferiche di bloccaggio del lumino stesso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 332143

Country of ref document: ES